Clinical trial

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients…

NCT00004011 · SWOG Cancer Research Network, Other · Completed

Key facts

NCT number NCT00004011
Title S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Official title A Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group North Central Cancer Treatment Group Radiation Therapy Oncology Group
Status Completed
Phase Phase 3
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Procedure
Interventions carboplatin, paclitaxel, conventional surgery
Enrollment 354
Start date Oct 1, 1999
Primary completion May 1, 2005
Completion Nov 1, 2012
First posted Jan 27, 2003
Last update posted Jan 31, 2013
Countries Canada, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies